BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23047386)

  • 1. The value of endoscopic ultrasonography in defining longitudinal gross target volumes for esophageal squamous carcinoma.
    Qiu GQ; Du XH; Yu JP; Zheng YD; Luo HJ; Xu YP; Chen JX; Sun XJ; Ji YL; Tao YL
    Surg Laparosc Endosc Percutan Tech; 2012 Oct; 22(5):424-8. PubMed ID: 23047386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
    Konski A; Doss M; Milestone B; Haluszka O; Hanlon A; Freedman G; Adler L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1123-8. PubMed ID: 15752892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.
    Zhang G; Han D; Ma C; Lu J; Sun T; Liu T; Zhu J; Zhou J; Yin Y
    Radiat Oncol; 2015 Jan; 10():11. PubMed ID: 25572431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer.
    Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Jiang GL; Chang JY
    Radiother Oncol; 2009 Dec; 93(3):441-6. PubMed ID: 19682760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma].
    Xu Q; Zhu SC; Liu ZK; Cao YK; Song CL; Li YM; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):432-5. PubMed ID: 20819484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
    Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer.
    Thomas E; Crellin A; Harris K; Swift S; Montefiore DS
    Radiother Oncol; 2004 Nov; 73(2):149-51. PubMed ID: 15542161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma].
    Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma.
    Hou DL; Shi GF; Gao XS; Asaumi J; Li XY; Liu H; Yao C; Chang JY
    Radiat Oncol; 2013 Jul; 8():169. PubMed ID: 23829638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers.
    Machiels M; van Hooft J; Jin P; van Berge Henegouwen MI; van Laarhoven HM; Alderliesten T; Hulshof MC
    Gastrointest Endosc; 2015 Oct; 82(4):641-9. PubMed ID: 25957478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study.
    Tan J; Lim Joon D; Fitt G; Wada M; Lim Joon M; Mercuri A; Marr M; Chao M; Khoo V
    J Med Imaging Radiat Oncol; 2010 Dec; 54(6):562-8. PubMed ID: 21199435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
    Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.
    Lee TH; Ryoo HG; Lee R; Paeng JC; Chung H; Kim HJ
    Medicine (Baltimore); 2021 Jun; 100(24):e26338. PubMed ID: 34128879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound: impact on survival in patients with esophageal cancer.
    Schrager JJ; Tarpley JL; Smalley WE; Austin MT; Pearson AS
    Am J Surg; 2005 Nov; 190(5):682-6. PubMed ID: 16226939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
    Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
    Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.